-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Barinthus Biotherapeutics plc. quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from Q1 2020 to Q3 2025.
- Barinthus Biotherapeutics plc. Net Income (Loss) Attributable to Parent for the quarter ending 30 Sep 2025 was -$14.6M, a 79.5% decline year-over-year.
- Barinthus Biotherapeutics plc. Net Income (Loss) Attributable to Parent for the twelve months ending 30 Sep 2025 was -$75.9M, a 31.2% decline year-over-year.
- Barinthus Biotherapeutics plc. annual Net Income (Loss) Attributable to Parent for 2024 was -$61.1M, a 16.7% increase from 2023.
- Barinthus Biotherapeutics plc. annual Net Income (Loss) Attributable to Parent for 2023 was -$73.3M, a 1473% decline from 2022.
- Barinthus Biotherapeutics plc. annual Net Income (Loss) Attributable to Parent for 2022 was $5.34M.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)